The presence of additional cytogenetic abnormalities (<scp>ACAs</scp>) or Philadelphia chromosome variants do not adversely affect the achievement of treatment‐free remission in chronic myeloid leukemia
Authors: Fadi G. Haddad, Koji Sasaki, Ghayas C. Issa, Elias Jabbour, Hagop Kantarjian